Revolution Medicines, Inc. (RVMD)
211.58
+2.12
(+1.01%)
USD |
NASDAQ |
Aug 24, 16:00
211.40
-0.18
(-0.09%)
After-Hours: 20:00
Revolution Medicines Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -285.2% |
| September 30, 2023 | |
| June 30, 2023 | 53.63% |
| March 31, 2023 | 63.89% |
| December 31, 2022 | 83.05% |
| September 30, 2022 | 27.50% |
| June 30, 2022 | 74.40% |
| March 31, 2022 | 69.78% |
| December 31, 2021 | 78.20% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 93.32% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | -- |
| Erasca, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
| Intellia Therapeutics, Inc. | 72.58% |
| Beam Therapeutics, Inc. | -1.00K% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -96.11% |
| Return on Assets | -64.69% |
| Return on Invested Capital | -76.58% |
| Return on Net Operating Assets | -764.8% |